Preservation of ischemic myocardial function and integrity with targeted cytoskeleton-specific immunoliposomes

Journal of the American College of Cardiology

Volumn 43, Issue 9, 2004, Pages 1683-1689

  Khudairi, Tala ^a   Khaw, Ban An ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b Molec Targeting Targeting T   (United States)

Author keywords

acute myocardial infarction; AMI; coronary perfusion pressure; CPP; CSIL; cytoskeletal specific immunoliposomes; IgG L; immunoglobulin G liposomes; left ventricle ventricular; left ventricular developed pressure; LV; LVDP; NBT; NGPE; nitro blue tetrazolium

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOLIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; DRUG TARGETING; HEART CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HISTOCHEMISTRY; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; ANTIBODY SPECIFICITY; CYTOSKELETON; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; LIPOSOMES; MALE; MITOCHONDRIA, HEART; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; PLACEBOS; RATS; RECOVERY OF FUNCTION; SINGLE-BLIND METHOD; TIME FACTORS; VENTRICULAR PRESSURE;

EID: 2342442144     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.11.054     Document Type: Article

References (37)

1. Mortality from coronary heart disease and acute myocardial infarction. MMWR 2001;50:90-3
2. Casey K., Bedker D.L., Roussel-McElmeel P.L. Myocardial infarction a review of clinical trials and treatment strategies. Clin Care Nurse. 18:1998;39-52
3. Majno G., Joris I. Apoptosis, oncosis, and necrosis an overview of cell death. Am J Pathol. 146:1995;3-15
4. Braunwald E., Kloner R.A. Myocardial reperfusion a double-edged sword. J Clin Invest. 76:1985;1713-1719
5. Takashi E., Ashraf M. Pathologic assessment of myocardial cell necrosis and apoptosis after ischemia and reperfusion with molecular and morphological markers. J Mol Cell Cardiol. 32:2000;209-224
6. Khaw B.A., Torchilin V.P., Vural I., Narula J. Plug and seal prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nat Med. 1:1995;1195-1198
7. Narula J., Nicol P.D., Southern J.F., et al. Evaluation of myocardial infarct size before and after reperfusion dual tracer imaging with radiolabeled antimyosin antibody. J Nucl Med. 35:1994;1076-1085
8. 99mTc-antimyosin antibody imaging for the detection of acute myocardial infarction in human beings. Am Heart J. 126:1993;536-542
9. Yasuda T., Palacios I.F., Dec G.W., et al. Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation. 76:1987;306-311
10. 111In monoclonal antimyosin. Am J Cardiol. 62:1988;623-627
11. Lasic D.D. Liposomes from Physics to Applications. 1993;Elsevier Science Publishers B.V, Amsterdam
12. Gregoriadis G. Liposomes as a drug delivery system optimization studies. Adv Exp Med Biol. 238:1988;151-159
13. Park J.W., Hong K., Kirpotin D.B., et al. Anti-HER2 immunoliposomes enhanced efficacy attributable to targeted delivery. Clin Cancer Res. 8:2002;1172-1181
14. Koning G.A., Kamps J.A., Scherphof G.L. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes. Cancer Detect Prev. 26:2002;299-307
15. Xu L., Huang C.C., Huang W., et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther. 1:2002;337-346
16. Khaw B.A., daSilva J., Vural I., Narula J., Torchilin V.P. Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes. J Control Rel. 75:2001;199-210
17. Sweadner K.J., Grail K.M., Khaw B.A. Discoordinate regulation of isoforms of Na, K-ATPase and myosin heavy chain in the hypothyroid postnatal rat heart and skeletal muscle. J Biol Chem. 26:1992;769-773
18. Khaw B.A., Mattis J.A., Melincoff G., Strauss H.W., Gold H.K., Haber E. Monoclonal antibody to cardiac myosin scintigraphic imaging of experimental myocardial infarction. Hybridoma. 3:1984;11-23
19. Ey P.L., Prowse S.J., Jenkin C.R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 15:1978;429-436
20. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, ELISA. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 109:1972;129-135
21. Weissig V., Lasch J., Klibanov A.L., Torchilin V.P. A new hydrophobic anchor for the attachment of proteins to liposomal membranes. FEBS Lett. 202:1986;86-90
22. Mori A., Huang L. Immunoliposome targeting in a mouse model optimization and therapeutic application. Gregoratos G. Liposome Technology. 3:1993;153-163 CRC Press, Boca Raton, FL
23. Neely J.R., Rovetto M.J. Techniques for perfusing isolated rat hearts. Methods Enzymol. 6:1975;43-60
24. Bozzola J.J., Russell L.D. Electron Microscopy: Principles and Techniques for Biologists. 1992;Jones and Bartlett, Boston, MA
25. Zar J.H. Biostatistical Analysis. 4th edition:1999;Prentice-Hall, Upper Saddle River, NJ
26. Jennings R.B., Schaper J., Hill M.L., Steenbergen C., Reimer K.A. Effect of reperfusion late in the phase of reversible ischemic injury changes in volume, electrolytes, metabolites, and ultrastructure. Circ Res. 56:1985;262-278
27. Jennings R.B., Sommers H.M., Smyth G.A., Flack H.A., Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol. 70:1960;68-78
28. Koba S., Konno N., Suzuki H., Katagiri T. Disruption of sarcolemmal integrity during ischemia and reperfusion of canine hearts as monitored by use of lanthanum ions and a specific probe. Basic Res Cardiol. 90:1995;203-210
29. Shuster M., Dickinson D. Recommendations for ensuring early thrombolytic therapy for acute myocardial infarction. Can Med Assoc J. 154:1996;483-487
30. Reimer K.A., Jennings R.B. Myocardial ischemia, hypoxia, and infarction. Fozzard H.A., Haber E., Jennings R.B. The Heart and Cardiovascular System. 2nd edition:1992;1875-1953 Raven Press, New York, NY
31. Roberts R., Morris D., Pratt C.M. Pathophysiology, recognition, and treatment of acute myocardial infarction and its complications. Schlant R.C., Alexander R.W. Hurst's the Heart Arteries and Veins. 8th edition:1994;1107-1184 McGraw Hill, New York, NY
32. Herse D.J., Garlick P.B., Humphrey S.M. Ischemic contracture of the myocardium mechanisms and prevention. Am J Cardiol. 39:1977;986-993
33. Dobrinina O.V., Shatinina S.Z., Archakov A. Phosphatidylcholine liposomes in the repair of hepaocyte plasma membrane. Bull Exp Biol Med. 110:1990;94-96
34. Whitman G., Kieval R., Wetstein L., Seeholzer S., McDonald G., Harken A. The relationship between global myocardial redox state and high energy phosphate profile a phosphorous-31 nuclear magnetic resonance study. J Surg Res. 33:1983;332-339
35. Ganote C.E., Nayler W.G. Contracture and the calcium paradox. J Mol Cell Cardiol. 17:1985;733-745
36. Murphy J.G., Marsh J.D., Smith T.W. The role of calcium in ischemic myocardial injury. Circulation. 75:(Suppl V):1987;V15-24
37. Navartnam V. Heart Muscle Ultrastructural Studies. 1987;Cambridge University Press, Cambridge, NY